To investigate the mutation inducibility of surfactin C, we performed the chromosome aberration assay with Chinese hamster lung cells in vitro. The colorimetric MIT screening assay was carried out to determine the cytotoxicity index (IC5o) of surfactin C. The IC50 value was 125 flg/ml. For the chromosome aberration test of surfactin C, the maximum concentration was employed as 125 flg/ml, followed by 62.5 and 31.25 flg/ml for the lower concentrations, with or without metabolic activation (S9). Cyclophosphamide and mitomycin C were used as positive controls in the presence and absence of S9 metabolic activation, respectively. These results showed that surfactin C was not capable of inducing chromosome aberration, as measured by the chromosome aberration test using Chinese hamster lung cell line. There is no evidence for surfactin C to have a genotoxic potential.
INTRODUCTION
Biosurfactants are proteins with detergent, emulsifier, and antimicrobial actions that have potential application in environmental applications such as the treatment of organic pollutants and oil recovery (Georgiou et al., 1990; Desai and Banat, 1997; Banat et al., 2000; Rodrigues et al., 2006) . Especially, microbial surfactants have several advantages over synthetic surfactants such as lower toxicity, easier biodegradability, better environmental compatibility, higher selectivity and specific activity at extreme temperatures, pH and salinity (Georgiou et al., 1990; Desai and Banat, 1997; Banat et al., 2000; Rodrigues et al., 2006) . Surfactin showed that it had a strong surface tension-lowering activity and showed antiviral, antitumor, fibrinolytic and hypocholesterolemic activities (Arima et Correspondence to: Jong-Hwan Lim, B&C Biopharm, Advanced Institutes of Convergence Technology, 906-5 luidong, Yeongtonggu, Suwonsi, Gyeonggido 443-270, Korea E-mail: jhlim99@empal.com and Hyo-In Yun, Institute of Veterinary Animal Science, College of Veterinary Medicine, Chungnam National University, 220, Gungdong, Yuseonggu, Daejeon 305-764, Korea E-mail: hiyun@cnu.ac.kr al., 1968; Singh and Cameotra, 2004; Mulligan, 2005) . It is a mixture of isofoms which slightly differ in their physiological properties due to a variation in the chain length and branching of its hydroxy fatty acid component as well as substitutions of the amino acid components of the peptide ring (Kanatomo et al., 1995) . Among of them, surfactin C ( Fig. 1 ) enhanced endogenous thrombolytic reactions by activation of plasminogen activator and inhibition of platelet aggregation (Kikuch and Hasumi, 2002; Lim et al., 2005) . It showed antimicrobial activity against methicillin-resis-H'C~,. l~):l 
MATERIALS AND METHODS
Chemicals. Surfactin C (purity > 98%) produced from Bacillus subtilis BC1212 was kindly obtained from B&C Biopharm (Suwon, Korea). Cyclophosphamide (Sigma, USA) and mitomycin C (Singm, USA) were served as positive controls. Rat liver S9 induced with Aroclor 1254 (Moltox Inc, USA) was used for metabolic activation.
Chinese hamster lung (CHL) cell line. CHL cells were purchased from the American Type Culture Collection (ATCC, USA) and cultured in Eagle's minimal essential medium (EMEM, Hyclone, USA), supplemented with 10% fetal bovine serum (FBS, Hyclone, USA), in a 37°C incubator containing 5% CO2 without any antibiotics or anti-mycotics. Subcultures were carried out every 2 days, using 0.03% Puck's EDTA and 0.25% Trypsin-EDTA solutions.
MIT assay. Cytotoxicity assay was performed using a two-fold serial dilution gradient of surfactin C concentrations, ranging from 15.6-1000 flg/mL. All treatments were performed in triplicate and the cells were cultured for 18 h in the presence and absence of surfactin C. An IC 50 concentration was determined from each of the three experiments and the final IC 50 was determined by averaging the values of the three experiments (± SO). The IC 50 is defined as the cytotoxicity index that reduces the cell number (by growth inhibition and/or cell killing) to 50% compared with untreatedcontrol CHL cells. The IC 50 value was used to determine the chromosomal aberration assay concentration ranges.
Chromosomal aberration assay. The assay was performed according to OECD and scientific guidelines (Galloway et a/., 1994; OECD, 1997) . For the shortperiod assay with or without S9 mix, CHL cells (2 x 10 5 cells/0.5 ml) were seeded in a 24 well plate culture dish, and incubated in a culture medium for overnight. The surfactin C was added with or without S9 mix and the cultures were incubated for 6 hr. After the 6 hr treatment, the cells were washed with phosphate buffered saline (PBS), and incubated in fresh culture medium for a further 18 h. The continuous treatment test was carried out for 24 h treatment without S9 mix. PBS was used as a negative control, while 20 fl9/ml cyclophosphamide (Sigma, USA) and 0.1 flg/ml mitomycin C (Sigma, USA) were used as positive controls for experiments conducted with and without metabolic activation, respectively (Galloway et a/., 1994) . The cells were treated with colchicine (Sigma, USA; 0.1 flM of final concentration) 2 h before cell harvesting. The cells were trypsinized and incubated in a 75 mM hypotonic KCI solution for 20 min at 37°C. Fixed with acetic acid-ethanol (1 : 3 by VOlume), and then spread onto clean glass slides. Each slide was stained with 5% Giemsa solution.
Duplicate cultures were used for each experiment. Cells were harvested 24 h after treatment initiation and a minimum of 200 metaphases (100 from each of two duplicate cultures) were analyzed for chromosome damage. Aberrations were classified according to Scott et at. (1983) into chromosome and chromatid type damage, with further subdivision into deletions and exchanges. Polyploidy and endoreduplication were recorded as a percentage per 100 metaphases counted.
The frequencies of structural or numerical aberrations were evaluated by the following criteria; less than 5%, 5% to less than 10%, and 10% or more were defined as negative (-), equivocal (±) and positive (+), respectively. The result was considered to be positive if reproducibility was confirmed. Total frequencies of structural aberrations excluded the frequencies of aberrant cells that have gaps only without other aberrations.
Statistical analysis. Statistical analysis was performed using SPSS 12.0k. The differences in the frequency of chromosomal aberrations between groups treated with surfactin C and controls were analyzed by the Fisher's exact test. P-values of less than 0.05 were considered to be consistent with statistical significance.
RESULTS AND DISCUSSION
Genotoxicity is the study of the toxic effects of chemicalor physical substances to the gene pool, where damages and/or changes to the genetic code or DNA sequence usually occur (Scott et al., 1983) . Genotoxic insults may be studied by use of mutagenicity, carcinogenicity and/or teratogenicity assays, due to the close relationship of these three phenomena (Scott et al., 1983; O'Brien et al., 1996; Dearfield et al., 2002) . Chemicals that are not known to cause any chromatogenic aberration must first be tested for the evidence of cytotoxicity in the system chosen for genotoxicity testing (Scott et al., 1983) . This would help the establishment of a maximum tolerated dose (MTD) of the chemical being tested, as described above for the mitotic index assay. In our study, the MTT cytotoxicity assay was employed in determining the dose responses of surfactin C directly without any metabolic activation. The IC 50 value of surfactin C was found 125 Ilg/ml. To evaluate the genotoxic activities of surfactin C, we carried out in vitro mutagenicity assays. The results obtained in the short-treatment assays for surfactin C with or without S9 mix were shown in Table 1 and 2. In the short-treatments with or without S9 mix, the structural chromosomal aberrations and polyploidy rates were less than 5% for any concentration of the surfactin C. For the continuous treatments test, structural chromosomal aberrations and the polyploidy induction rates were less than 5% at any concentration in both the 24 hr (Table 3 and 4). Based on these data, surfactin C did not induced structural chromosomal aberrations in the short-treatments test and continuous treatment.
The results suggested that surfactin C has no clastogenic potential in cultured mammalian cells either with or without 89 activation. This is consistent with the previous reports that surfactin C is negative with or without metabolic activation in mutation assay using Salmonella typhimurium and Escherichia coli (Hwang et al., 2008) .
